Since the approval of Enbrel?, CD4-Fc fusion protein (for the treatment of rheumatoid arthritis) in 1998, Fc fusion therapies have evolved into a prominent class of therapeutics.[1] Currently, 13 Fc fusion drugs are commercially available, while around 50 molecules are under development for various disease indications.
Mê Truyện Qq
Geeta University
Ae888betvn Com
Paisley Genesis
Chapman Education
Dr. Imran S. Khawaja
Veni Vici Marketing
Wags Petcare Asia
Limo Ann Arbor
Cho Thue Nha